Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence study of generic sacubitril/valsartan 97/103 mg vs Entresto in healthy Thai volunteers (fasting)
TCTR20250129002Phase 4Unknown
- Sponsor
- International Bio Service
- Start
- Mar 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of sacubitril + valsartan in heart failure (HF) (2 arms), sponsored by International Bio Service. Status: unknown.
02
Drugs
sacubitril + valsartan
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on TCTR20250129002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20250129002.